assay
simultan
detect
multipl
potenti
agent
bioterror
limit
two
multiplex
pcr
rtpcr
enzym
hybrid
assay
mpcreha
mrtpcreha
develop
simultan
detect
mani
cdc
categori
bioterror
agent
bio
dna
assay
develop
detect
variola
major
vm
bacillu
anthraci
ba
yersinia
pesti
yp
francisella
tularensi
ft
varicella
zoster
viru
vzv
bio
rna
assay
mrtpcreha
develop
detect
ebola
viru
ebola
lassa
fever
viru
lassa
rift
valley
fever
rvf
hantaviru
sin
nombr
speci
hsn
dengu
viru
serotyp
sensit
specif
assay
test
use
genom
dna
recombin
plasmid
posit
control
rna
transcript
control
surrog
spike
clinic
sampl
common
respiratori
pathogen
analyt
sensit
limit
detect
lod
dna
asssay
virus
rvf
lassa
hsn
crossreact
primer
probe
use
assay
detect
common
respiratori
pathogen
target
analyt
clinic
sensit
estim
use
surrog
clinic
sampl
test
biot
dna
assay
sampl
test
biot
rna
assay
clinic
specif
biot
dna
assay
biot
rna
assay
respect
surrog
sensit
two
assay
ci
ft
ba
yp
vm
vzv
dengu
ci
ba
dengu
use
spike
clinic
specimen
specif
biot
multiplex
assay
spike
specimen
ci
compar
avail
assay
cultur
serolog
pcr
etc
biot
dna
mpcreha
biot
rna
mrtpcreha
rapid
sensit
specif
assay
detect
mani
categori
bioterror
agent
use
standard
thermocycl
biolog
weapon
pose
signific
threat
mani
virul
pathogen
organ
use
individu
togeth
weapon
use
could
caus
high
rate
morbid
mortal
among
popul
also
signific
societ
disrupt
cost
center
diseas
control
prevent
classifi
biolog
agent
categori
b
c
agent
base
potenti
threat
categori
bioterror
agent
includ
variola
major
vm
smallpox
bacillu
anthraci
ba
anthrax
yersinia
pesti
yp
plagu
clostridium
botulinum
botul
francisella
tularensi
ft
tularemia
group
rna
virus
caus
hemorrhag
fever
vhf
lassa
fever
viru
new
world
arenavirus
arenavirida
rift
valley
fever
rvf
hantaviru
bunyavirida
ebola
viru
marburg
virus
filovirida
dengu
viru
omsk
hemorrhag
fever
viru
kyanasur
forest
diseas
viru
flavivirida
suspect
bioterrorist
attack
rapid
diagnosi
critic
effect
public
health
respons
treatment
variou
dna
organ
specif
would
possibl
caus
organ
promptli
identifi
describ
rna
virus
except
dengu
highli
infecti
aerosol
transmiss
specif
treatment
demonstr
safe
effect
hemorrhag
fever
rapid
screen
suspect
sampl
would
help
control
spread
ensur
accur
treatment
diseas
current
avail
diagnost
test
cdc
categori
bioterror
agent
eg
cell
cultur
serolog
time
consum
less
optim
sensit
specif
test
multipl
agent
simultan
newer
molecular
method
either
singleplex
realtim
pcr
assay
avail
outsid
cdc
lrn
network
small
commerci
multiplex
pcr
assay
link
expens
machin
also
easili
avail
need
precis
rapid
simpl
robust
diagnost
assay
detect
larg
number
agent
clinic
treatment
prevent
panic
among
public
author
larg
multiplex
pcr
assay
advantag
detect
mani
pathogen
clinic
sampl
hour
highli
sensit
specif
present
studi
two
larg
multiplexpcr
assay
develop
simultan
detect
mani
cdc
categori
dna
rna
base
bioterror
agent
biot
dna
multiplex
pcrenzym
hybrid
assay
biot
dna
mpcreha
develop
simultan
detect
vm
ba
yp
ft
biot
rna
multiplex
revers
transcript
pcreha
biot
rna
mrtpcreha
develop
simultan
detect
ebola
viru
lassa
viru
rvf
viru
hanta
viru
sin
nombr
speci
hsn
dengu
viru
serotyp
varicellazost
viru
categori
agent
chosen
target
biot
dna
assay
order
posit
identifi
caus
rash
lesion
suspect
smallpox
patient
assay
analyt
sensit
determin
test
duplic
dna
sampl
rna
transcript
whole
organ
differ
analyt
repeat
least
three
time
determin
assay
reproduc
lod
determin
lowest
dilut
gave
posit
eha
read
greater
lod
dna
assay
genom
dna
whole
organ
shown
tabl
lod
genom
dna
copiesml
ba
ft
copiesml
ba
copiesml
yp
lod
vzv
whole
organ
tcid
ml
lod
recombin
plasmid
dna
control
evalu
way
shown
tabl
lod
ba
ba
recombin
control
copiesml
analyt
sensit
ft
yp
vm
copiesml
respect
lod
rna
assay
without
extract
rna
transcript
control
shown
tabl
lod
without
extract
rna
transcript
control
copiesml
ebola
rvf
copiesml
lassa
copiesml
hsn
lod
extract
rna
transcript
control
copiesml
ebola
lassa
hsn
copiesml
rvf
lod
dengu
whole
organ
serotyp
shown
tabl
lod
dengu
whole
organ
approxim
dilut
dengu
ld
ml
dengu
ld
ml
dengu
lod
without
extract
recombin
plasmid
dna
control
evalu
way
shown
tabl
lod
without
extract
recombin
plasmid
dna
control
copiesml
target
demonstr
outstand
sensit
input
copiesreact
primer
probe
rna
assay
pcreha
suggest
rna
control
repres
lod
would
expect
see
true
clinic
test
hypothes
rna
transcript
unstabl
degrad
like
dilut
extract
process
analyt
specif
assay
determin
use
number
close
relat
organ
common
respiratori
pathogen
might
found
clinic
sampl
sampl
test
crossreact
primer
probe
tabl
describ
organ
dilut
use
result
posit
od
read
averag
od
read
duplic
sampl
crossreact
primer
probe
organ
detect
either
assay
intern
control
probe
rna
assay
identifi
human
parainfluenza
viru
rna
assay
use
intern
control
produc
neg
result
primer
probe
assay
except
intern
control
posit
two
hundr
sixti
four
clinic
sampl
np
swab
skin
swab
serum
sputum
tracheal
test
dna
assay
result
shown
tabl
test
three
indetermin
ft
reprob
per
standard
protocol
indetermin
od
found
neg
one
fals
posit
low
posit
ft
retest
also
found
neg
clinic
specif
biot
dna
assay
ci
clinic
sampl
test
rna
assay
one
fals
posit
hsn
retest
per
standard
protocol
fals
posit
od
found
neg
overal
clinic
specif
biot
rna
assay
ci
result
shown
tabl
one
sampl
posit
vzv
clinic
specimen
spike
vm
use
standard
assay
protocol
reprob
posit
minut
procedur
found
true
neg
like
technic
error
howev
even
count
fals
posit
would
much
impact
specif
vzv
ci
one
sampl
test
low
posit
vm
ba
spike
sampl
reprob
pcr
product
continu
show
sampl
posit
howev
retest
origin
clinic
sampl
demonstr
neg
therefor
repres
true
fals
posit
sampl
specif
vm
ci
fals
posit
detect
use
ft
ba
ba
yp
probe
specif
ci
final
neg
control
sampl
neg
organ
total
serum
specimen
use
test
surrog
clinic
sensit
specif
rna
assay
result
shown
tabl
dengu
serum
sampl
spike
correctli
detect
result
sensit
ci
dengu
test
show
sampl
correctli
detect
sensit
ci
fals
posit
result
found
use
probe
includ
ebola
hsn
rvf
lassa
biot
rna
assay
show
specif
ci
neg
control
sampl
neg
target
make
overal
specif
assay
ci
current
studi
describ
develop
two
multiplex
assay
detect
mani
cdc
categori
bioterror
agent
simultan
first
multiplex
assay
detect
b
anthraci
f
tularensi
pesti
vmajor
varicella
zoster
viru
second
multiplex
assay
detect
ebola
viru
zair
lassa
fever
viru
rift
valley
fever
viru
hantaviru
sin
nombr
dengu
viru
serotyp
varicellazost
viru
categori
agent
chosen
target
biot
dna
assay
order
posit
identifi
possibl
caus
rash
lesion
suspect
smallpox
patient
addit
demonstr
clinic
sampl
vm
neg
presum
virtual
patient
come
hospit
emerg
room
concern
vm
actual
viru
short
bioterror
attack
virul
b
anthraci
associ
two
mega
plasmid
plasmid
mda
carri
gene
requir
synthesi
antiphagocyt
polydglutam
acid
capsul
facilit
host
immun
system
evas
plasmid
requir
synthesi
three
anthrax
toxin
protein
edema
factor
ef
lethal
factor
lf
protect
antigen
pa
protein
act
binari
combin
produc
two
anthrax
toxin
edema
toxin
pa
ef
lethal
toxin
pa
lf
isol
lack
either
plasmid
consid
either
avirul
significantli
attenu
present
studi
set
primer
probe
design
conserv
region
pa
cap
gene
locat
respect
plasmid
b
anthraci
clinic
sampl
give
posit
signal
primer
probe
set
consid
posit
ba
sinc
demonstr
high
sensit
specif
primer
probe
set
assay
work
well
detect
target
ba
analyt
test
multiplex
assay
demonstr
excel
lod
input
copi
analyt
signific
cross
reactiv
larg
number
agent
might
clinic
sampl
clinic
sampl
type
use
biot
dna
assay
spike
experi
meet
cdc
requir
appropri
diagnost
sampl
categori
agent
cdc
requir
collect
blood
skin
lesion
respiratori
secret
diagnosi
b
anthraci
respiratori
secret
blood
collect
diagnosi
f
tularensi
especi
inhal
tularemia
blood
lymphoid
tissu
specimen
collect
diagnosi
pesti
bronchialtrach
wash
taken
suspect
pneumon
plagu
patient
skin
vesicl
top
taken
diagnosi
vm
cdc
prefer
collect
blood
biopsi
materi
lung
bone
marrow
aspir
pcr
diagnosi
vhf
consid
cdc
requir
np
swab
specimen
chosen
creat
surrog
posit
clinic
sampl
use
spike
experi
b
anthraci
pesti
f
tularensi
skin
swab
specimen
chosen
v
major
varicella
zoster
viru
serum
specimen
chosen
spike
experi
dengu
viru
evalu
clinic
specimen
specimen
total
test
demonstr
high
sensit
spike
sampl
specif
spike
unspik
sampl
confirm
assay
applic
test
differ
clinic
sampl
without
inhibit
crossreact
demonstr
potenti
util
clinic
public
health
use
mani
molecular
diagnost
method
develop
detect
bioterror
agent
realtim
pcr
microarray
current
two
commonli
report
molecular
diagnost
method
mgb
probebas
realtim
pcr
assay
develop
detect
pesti
f
tularensi
b
anthraci
simultan
test
sampl
must
test
simultan
seper
singleplex
assay
three
target
two
commerci
triplex
multiplex
real
time
pcr
kit
machin
develop
cepheid
idaho
technolog
inc
detect
b
anthraci
pesti
f
tularensi
howev
assay
use
machin
therefor
laboratori
standard
thermocycl
realtim
machin
run
assay
unabl
purchas
reagent
comparison
test
viral
hemorrhag
fever
agent
sever
taqman
sybr
green
realtim
onestep
rtpcr
assay
develop
detect
serotyp
dengu
singletub
multiplex
pcr
develop
identifi
serotyp
dengu
viru
previous
screen
realtim
pcr
detect
ebola
viru
rvf
lassa
still
depend
serolog
test
laboratori
addit
rtpcr
method
recent
develop
german
group
establish
onestep
realtim
rtpcr
assay
ebola
viru
marburg
viru
lassa
viru
crimeancongo
hemorrhag
fever
viru
rift
valley
fever
viru
rvfv
dengu
viru
denv
yellow
fever
viru
yfv
assay
distinguish
target
simultan
biot
multiplex
dna
rna
assay
two
new
method
compliment
exist
test
strategi
possibl
advantag
publish
method
includ
increas
number
analyt
per
test
vs
stabil
reagent
use
common
technolog
cost
realtim
reagent
shorter
shelf
live
hrp
label
reagent
use
fluoresc
probe
addit
assay
util
standard
pcr
thermocycl
elisa
plate
reader
cost
ten
thousand
dollar
less
realtim
pcr
machin
reagent
cost
multiplex
pcreha
format
less
realtim
reagent
addit
side
side
compar
research
perform
assess
multiplex
biot
dna
rna
assay
exist
method
biot
dna
assay
biot
rna
assay
develop
use
manual
nucleic
acid
extract
roch
method
requir
skill
technician
labor
intens
recent
increas
use
autom
sampl
prepar
use
system
roch
magnapur
compact
qiagen
biorobot
biomerieux
nuclisen
extractor
robot
system
dramat
increas
throughput
decreas
handson
time
recent
demonstr
dramat
decreas
technician
time
half
use
autom
extract
eha
detect
autom
microarray
detect
howev
autom
hidden
variabl
effect
cost
sensit
reproduc
chemistri
assay
includ
buffer
enzym
use
especi
target
rna
vs
dna
size
clinic
matrix
affect
result
obtain
autom
system
demonstr
biot
dna
assay
sensit
use
roch
high
pure
viral
nucleic
acid
kit
extract
one
log
better
use
roch
magnapur
compact
system
also
less
consist
reproduc
data
shown
ultim
goal
laboratori
develop
fulli
contain
autom
handsoff
devic
extract
nucleic
acid
amplifi
target
detect
fast
accur
inexpens
technolog
must
robust
flexibl
differ
target
matrix
materi
transport
medium
clinic
materi
medium
larg
multiplex
assay
describ
paper
step
direct
primer
probe
use
assay
design
highli
conserv
region
specif
gene
organ
list
tabl
primer
probe
dna
assay
specif
target
gene
f
tularensi
ha
gene
v
major
gene
varicella
zoster
viru
virul
antigen
gene
pesti
pair
primer
b
anthraci
design
conserv
region
protect
antigen
pa
cap
gene
locat
respect
plasmid
plasmid
requir
pathogen
primer
probe
rna
assay
specif
target
l
gene
ebola
gene
rvf
l
gene
lassa
segment
hanta
dengu
varicella
zoster
viru
vzv
four
serotyp
dengu
viru
obtain
atcc
genom
dna
ft
ba
ba
strain
obtain
medic
colleg
wisconsin
genom
dna
yp
obtain
blood
center
wisconsin
genom
dna
ba
ba
obtain
univers
chicago
creat
posit
control
pcr
product
gener
whole
organ
purifi
clone
plasmid
use
topo
ta
clone
system
invitrogen
carlsbad
ca
follow
manufactur
instruct
posit
control
sequenc
verifi
amplicon
sequenc
possibl
mismatch
gener
clone
posit
control
amplifi
gener
larg
quantiti
purifi
use
qiagen
plasmid
midi
kit
qiagen
valencia
ca
synthet
rna
standard
gener
linear
target
sequenc
plasmid
use
vitro
transcript
system
promega
madison
wi
quantiti
dna
rna
transcript
measur
absorb
nm
puriti
dna
rna
ratio
determin
approxim
copi
number
plasmid
control
synthet
rna
control
absorb
valu
posit
control
use
combin
avogadro
number
describ
khanna
et
al
rna
transcript
dilut
rnase
dnase
free
water
rnase
inhibitor
appli
biosystem
foster
citi
ca
frozen
aliquot
serial
dilut
plasmid
rna
transcript
use
establish
analyt
sensit
specif
biot
dna
rna
multiplex
assay
ten
extract
dna
amplifi
pcr
reaction
contain
mm
mgcl
appli
biosystem
dntp
appli
biosystem
pcr
buffer
ii
appli
biosystem
u
amplitaq
gold
dna
polymeras
appli
biosystem
pair
primer
final
concentr
forward
primer
revers
primer
amplif
perform
geneamp
thermocycl
appli
biosystem
pcr
carri
follow
condit
c
min
cycl
c
c
c
cycl
c
c
c
extens
step
c
min
biot
rna
assay
twostep
rtpcr
perform
geneamp
thermocycl
appli
biosystem
cdna
synthes
ul
reaction
mixtur
contain
mm
random
hexam
appli
biosystem
mm
dntp
appli
biosystem
mgcl
appli
biosystem
rnase
inhibitor
mulv
revers
transcriptas
appli
biosystem
rna
reaction
mixtur
incub
min
min
transcriptas
inactiv
min
next
cdna
amplifi
ad
multiplex
supermix
contain
pair
primer
appropri
buffer
u
amplitaq
gold
dna
polymeras
appli
biosystem
final
concentr
primer
forward
primer
revers
primer
amplif
perform
condit
biot
dna
assay
pcr
product
dna
rna
assay
purifi
use
qiaquick
pcr
purif
kit
qiagen
total
nm
horseradish
peroxidas
label
probe
solut
eurogentec
san
diego
ca
ad
well
well
neutravidinco
microtit
plate
pierc
rockford
il
hybrid
purifi
pcr
product
minut
plate
wash
time
wash
buffer
tetramethyl
benzidin
substrat
ad
experiment
well
reaction
stop
addit
stop
solut
h
absorb
optic
densiti
od
measur
nm
use
molecular
devic
spectrophotomet
posit
cut
valu
assay
chosen
four
time
greater
valu
neg
control
greater
equal
od
valu
analyt
sensit
dna
assay
determin
use
serial
dilut
dna
extract
whole
organ
recombin
dna
control
tenfold
serial
dilut
genom
dna
ba
yp
ft
previous
extract
whole
organ
plasmid
dna
control
made
copiesml
medium
remel
lenexa
ks
extract
use
high
pure
viral
nucleic
acid
kit
accord
manufactur
instruct
roch
appli
scienc
indianapoli
test
vzv
whole
organ
serial
dilut
cfuml
extract
use
method
analyt
sensit
rna
assay
determin
use
serial
dilut
rna
transcript
recombin
dna
control
hsn
rvf
lassa
ebola
viru
analyt
sensit
assay
dengu
determin
use
serial
dilut
four
serotyp
dengu
viru
tenfold
serial
dilut
rna
transcript
recombin
dna
control
made
copiesml
rna
transcript
copiesml
recombin
dna
control
use
two
matric
medium
rnasednasefre
water
rna
plasmid
control
dilut
water
use
templat
rtpcr
determin
limit
detect
lod
without
extract
rna
control
dilut
extract
determin
lod
extract
dengu
serotyp
whole
viru
serial
dilut
dilut
dengu
serotyp
viru
stock
serotyp
came
atcc
without
quantit
ld
ml
dengu
serotyp
ld
ml
dengu
serotyp
dilut
whole
virus
extract
use
high
pure
viral
nucleic
acid
kit
roch
accord
manufactur
instruct
test
specif
dna
rna
assay
evalu
respect
test
common
respiratori
pathogen
could
present
clinic
specimen
potenti
crossreact
atcc
bacteri
viral
strain
test
dna
assay
dilut
cfuml
tcid
ml
atcc
bacteri
viral
strain
test
rna
assay
dilut
cfuml
cfuml
tcid
ml
cellsml
respect
bacteri
viral
strain
test
use
method
previous
describ
plasmid
dna
control
whole
viru
target
biot
assay
dilut
test
log
higher
lod
use
method
rna
assay
clinic
sampl
np
swab
skin
swab
blood
sputum
tracheal
nasal
swab
test
sampl
collect
subject
describ
sampl
subject
respiratori
symptom
subject
respiratori
symptom
two
hundr
thirti
nine
sampl
children
age
year
old
children
age
year
old
subject
age
year
old
subject
older
clinic
sampl
test
femal
male
sampl
od
valu
lower
consid
neg
sampl
od
valu
consid
indetermin
reprob
confirm
result
sampl
od
valu
consid
posit
retest
evalu
perform
dna
assay
use
surrog
posit
clinic
sampl
total
clinic
np
swab
skin
swab
specimen
previous
test
neg
assay
use
spike
experi
twenti
clinic
specimen
spike
plasmid
dna
posit
control
six
transport
medium
specimen
set
neg
specimen
six
organ
mention
total
recombin
posit
control
ft
ba
spike
np
swab
specimen
concentr
copiesml
recombin
posit
control
yp
ba
spike
np
swab
specimen
concentr
copiesml
recombin
posit
control
vm
spike
skin
swab
sampl
concentr
copiesml
vzv
whole
organ
spike
skin
swab
specimen
tcid
ml
evalu
perform
rna
assay
posit
clinic
sampl
pool
serum
sampl
previous
test
neg
assay
aliquot
sampl
use
spike
experi
twenti
serum
sampl
spike
whole
organ
serotyp
dengu
viru
total
serum
sampl
run
neg
specimen
serotyp
dengu
viru
total
dengu
dengu
spike
dilut
concentr
log
higher
lod
dengu
log
higher
lod
dengu
dengu
spike
ld
ml
concentr
log
higher
lod
dengu
dengu
spike
ld
ml
concentr
log
higher
lod
dengu
spike
specimen
test
blindli
present
data
demonstr
multiplex
biot
dna
assay
biot
rna
assay
highli
sensit
specif
reproduc
test
genom
dna
recombin
plasmid
posit
control
rna
transcript
whole
organ
spike
clinic
specimen
util
standard
thermocycl
assay
also
rapid
hr
util
rel
inexpens
reagent
sampl
test
target
analyt
requir
littl
technician
time
per
sampl
hr
compar
current
avail
assay
laboratori
diagnosi
bioterror
agent
biot
assay
repres
use
new
tool
clinician
public
health
offici
need
detect
import
pathogen
peopl
either
natur
infect
manmad
exposur
bioterror
